70 results
Page 2 of 4
8-K
EX-1.1
fc5rfb6blaadsjhfjtzm
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
424B4
y4ydtzd
11 Oct 22
Prospectus supplement with pricing info
8:27am
8-K
4sew405zy 6k
25 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
EX-1.1
jdxv0c
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
424B5
a07kc57ijh
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
ttg40g779r6s5v
10 Dec 21
Prospectus supplement for primary offering
5:25pm
CORRESP
p7fpr4ssrn0ol0q5oj
9 Dec 21
Correspondence with SEC
12:00am
424B5
qxn8 ryu9it0h
10 Nov 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
1jkw5 c5f
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm